Cancer Genomics

CANLYTx®

CANLYTx® - a genomic-based clinical decision support system that investigates distinctive biomarkers from a patient's whole exome tumor DNA and RNA to accomplish personalized theragnostics. This enables your oncologist to arrive at an individualized treatment regimen based on therapies that suit you.

THE WAR AGAINST CANCER, CAN BE WON!

Kyvor Genomics

CANLYTx®

Ultra

DNA & RNA
&

Optimized therapy

Avoid trial & error with right medication, and prevent Adverse drug reactions

&

Reduced cost

Focusing on what works for each patient, lowering overall costs

&

Improved Outcomes

Faster recovery, minimizing illness impact on you and your family

Sample type

CANLYTx® Ultra requires an FFPE block and/or blood as the sample type

&

Largest Database

2500+ genes, 300,000+ variants, clinical studies & trials database



GET BROCHURE ORDER NOW

CANLYTx®

FFPE

TMB & MSI
&

Optimized therapy

Avoid trial & error with right medication, and prevent Adverse drug reactions

&

Reduced cost

Focusing on what works for each patient, lowering overall costs

&

Improved Outcomes

Faster recovery, minimizing illness impact on you and your family

Sample type

CANLYTx® FFPE requires an FFPE block as the sample type

&

Largest Database

1800 genes, 300,000+ variants, clinical studies & trials database



GET BROCHURE ORDER NOW

CANLYTx®

LB

Liquid Biopsy
&

Optimized therapy

Avoid trial & error with right medication, and prevent Adverse drug reactions

&

Reduced cost

Focusing on what works for each patient, lowering overall costs

&

Improved Outcomes

Faster recovery, minimizing illness impact on you and your family

Sample type

CANLYTX® LB requires peripheral blood/ plasma as the sample type

&

Largest Database

1800 genes, 300,000+ variants, clinical studies & trials database



GET BROCHURE ORDER NOW